Delivery Order SPE2DB20D2014-SPE2DB25FC50U
- Not listed
- The Defense Logistics Agency awarded a $5,184.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserina) 100 mg tablets in quantities of 30 units. This delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of ADDYI 100 mg tablets (30-count unit dose packaging) with a contract ceiling value of $6,180.54 and an ultimate completion date of August 4, 2025. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,935.74 delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) under a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This contract represents a non-set-aside, competitively awarded delivery order, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ADDYI 100 MG TABLET pharmaceuticals. The $3,199.38 order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA to provide a comprehensive range of medications and medical supplies to military treatment programs and facilities worldwide....
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,436.06 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565333877 ADDYI 100 MG TABLET UU 30S. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of the pharmaceutical product ADDYI 100 MG TABLET UU 30S, with a ceiling value of $6,302.29 and a period of performance through May 28, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,998.22 firm-fixed-price contract is for the delivery of 100 mg ADDYI tablets. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle. This enables the company to...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ADDYI 100 MG TABLET UU 30S. The firm fixed-price contract has a ceiling value of $3,720.22 and a completion date of November 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- This is a $10,721.88 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ADDYI 100 MG TABLET UU 30S, a medication, with a period of performance through February 10, 2025. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $2,291 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 100 milligram tablets of ADDYI to the agency. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from August 23 to August 24, 2023. The Defense Logistics Agency routinely utilizes indefinite-delivery/indefinite-quantity contracts to procure...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC50UDelivery Order
This delivery order, valued at $4,281.88, was awarded on July 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ADDYI (flibanserind) 100 mg tablets in quantities of 30 units. The contract employs firm fixed pricing with no set-aside designation, indicating competitive procurement. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains extensive federal contracting relationships with the DLA Medical Supply Chain. The company's IDC serves as a global vehicle enabling the supply of diverse pharmaceutical products and medical commodities to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. This specific delivery order for ADDYI reflects the company's role in providing specialized pharmaceutical products to federal healthcare systems. The DLA's Strategic approach of establishing multiple regional pharmaceutical prime vendor contracts demonstrates the agency's reliance on established distributors like AmerisourceBergen to meet critical medical supply requirements across the defense enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/18/25 |